Cognitive impairment in Parkinson's disease: Tools for diagnosis and assessment

Movement Disorders

Volumn 24, Issue 8, 2009, Pages 1103-1110

  Kulisevsky, Jaime ^a   Pagonabarraga, Javier ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cognition; Dementia; Neuropsychological; Parkinson's disease; Scale

Indexed keywords

CAMBRIDGE COGNITIVE ASSESSMENT; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CONTENT VALIDITY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FRONTAL ASSESSMENT BATTERY; FUNCTIONAL ASSESSMENT; HUMAN; INTERNAL CONSISTENCY; INTRARATER RELIABILITY; MATTIS DEMENTIA RATING SCALE; MINI MENTAL PARKINSON; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PARKINSON DISEASE COGNITIVE RATING SCALE; PARKINSON NEUROPSYCHOMETRIC DEMENTIA ASSESSMENT; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SCALES FOR OUTCOMES OF PARKINSON DISEASE; SENSITIVITY AND SPECIFICITY; TEST RETEST RELIABILITY; VALIDATION PROCESS;

COGNITION DISORDERS; HUMANS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 67651183991     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22506     Document Type: Review

References (53)

1. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991;114:2095-2122.
2. Goldman WP, Baty JD, Buckles VD, Sahrmann S, Morris JC. Cognitive and motor functioning in Parkinson disease: subjects with and without questionable dementia. Arch Neurol 1998;55: 674-680.
3. Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005;20:1255-1263.
4. Hobson P, Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov Disord 2004;19:1043-1049.
5. Aarsland D, Anderson K, Larsen JP, Lolk A, Nielsen H, Kragh-Sørensen. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 2001;56;730-736.
6. Buter TC, van den HA, Matthews FE, Larsen JP, Brayne C, Aarsland D. Dementia and survival in Parkinson disease: a 12-year population study. Neurology 2008;70:1017-1022.
7. Halliday G, Hely M, Reid W, Morris J. The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol 2008;115:409-415.
8. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005;65:1239-1245.
9. Janvin C, Aarsland D, Larsen JP, Hugdahl K. Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord 2003;15:126-131.
10. Weintraub D, Moberg PJ, Culbertson WC, Duda JE, Stern MB. Evidence for impaired encoding and retrieval memory profiles in Parkinson disease. Cogn Behav Neurol 2004;17:195-200.
11. Teipel SJ, Willoch F, Ishii K, et al. Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease. Neurobiol Aging 2006;27:681-690.
12. Stern Y, Marder K, Tang MX, Mayeux R. Antecedent clinical features associated with dementia in Parkinson's disease. Neurology 1993;43:1690-1692.
13. Galvin JE, Pollack J, Morris JC. Clinical phenotype of Parkinson disease dementia. Neurology 2006;67:1605-1611.
14. Royall DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry 1998;64:588-594.
15. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007;130:1787-1798.
16. Riedel O, Klotsche J, Spottke A, et al. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol 2008;255:255-264.
17. Mahieux FMM, Boller F, Fermanian J, Guillard G. Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease. Behav Neurology 1995;8:15-22.
18. Marinus J, Visser M, Verwey NA, et al. Assessment of cognition in Parkinson's disease. Neurology 2003;61:1222-1228.
19. Kalbe E, Calabrese P, Kohn N, et al. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord 2008;14:93-101.
20. Pagonabarraga J, Kulisevsky J, Llebaria G, Garcia-Sanchez C, Pascual-Sedano B, Gironell A. Parkinson's disease - cognitive rating scale (PD-CRS): A new cognitive scale specific for Parkinson's disease. Mov Disord 2008;23:998-1005.
21. McDowell NC, I. Measuring health: a guide to rating scales and questionnaires, 2nd ed. New York: Oxford University Press; 1996.
22. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707.
23. Nunnally JC. Psychometric theory, 3rd ed. New York: McGraw-Hill; 1994.
24. Fleiss JL. The measurement of inter-rater agreement. In: Fleiss JL, editor. Statistical methods for rates and proportions. New York: Wiley; 1981. p 212-236.
25. Feinstein AR. Clinometrics, 1st ed. New Haven: Yale University Press; 1987.
26. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995;4:293-307.
27. Brown GG, Rahill AA, Gorell JM, et al. Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease. J Geriatr Psychiatry Neurol 1999;12:180-188.
28. Wind AW, Schellevis FG, Van Staveren G, Scholten RP, Jonker C, Van Eijk JT. Limitations of the Mini-Mental State Examination in diagnosing dementia in general practice. Int J Geriatr Psychiatry 1997;12:101-108.
29. Zadikoff C, Fox SH, Tang-Wai DF, et al. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Mov Disord 2008;23:297-299.
30. Hobson P, Meara J. The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test. Age Ageing 1999;28:39-43.
31. Athey RJ, Porter RW, Walker RW. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R). Age Ageing 2005;34:268-273.
32. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000;55:1621-1626.
33. Verbaan D, Marinus J, Visser M, et al. Cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78: 1182-1187.
34. Carod-Artal FJ, Martinez-Martin P, Kummer W, Ribeiro LS. Psychometric attributes of the SCOPA-COG Brazilian version. Mov Disord 2008;23:81-87.
35. Di Virgilio G, Leroy A, Cunin P, Mahieux F, Bachoud-Levi AC, Fénelon G. The Mini Mental Parkinson brief cognitive test: comparison with the Mattis dementia rating scale in 289 patients with Parkinson's disease. Mov Disord 2007;22(Suppl 16):S90-S91.
36. Mattis S. Dementia rating scale: professional manual. Florida: Odessa; 1988.
37. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269:2386-2391.
38. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-709.
39. Monsch AU, Bondi MW, Salmon DP, et al. Clinical validity of the Mattis Dementia Rating Scale in detecting Dementia of the Alzheimer type. A double cross-validation and application to a community-dwelling sample. Arch Neurol 1995;52:899-904.
40. Aarsland D, Litvan I, Salmon D, Galasko D, Wentzel-Larsen T, Larsen JP. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003;74:1215-1220.
41. Hofer SM, Piccinin AM, Hershey D. Analysis of structure and discriminative power of the Mattis Dementia Rating Scale. J Clin Psychol 1996;52:395-409.
42. Vitaliano PP, Breen AR, Russo J, Albert M, Vitiello MV, Prinz PN. The clinical utility of the dementia rating scale for assessing Alzheimer patients. J Chronic Dis 1984;37:743-753.
43. Llebaria G, Pagonabarraga J, Kulisevsky J, García-Sánchez C, Pascual-Sedano B, Gironell A, Martínez-Corral M. Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease. Mov Disord 2008;23:1546-1550.
44. Schmidt R, Freidl W, Fazekas F, et al. The Mattis Dementia Rating Scale: normative data from 1,001 healthy volunteers. Neurology 1994;44:964-966.
45. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
46. Roth M, Huppert FA, Mountjoy CQ, Tym E. CAMDEX: the Cambridge examination for mental disorders. Cambridge: Cambridge University Press; 1988.
47. Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 2003;23:6351-6356.
48. Lipton AM, Ohman KA, Womack KB, Hynan LS, Ninman ET, Lacritz LH. Subscores of the FAB differentiate frontotemporal lobar degeneration from AD. Neurology 2005;65:726-731.
49. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006;30:1-23.
50. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007;22:2314-2324.
51. Huang C, Tang C, Feigin A, et al. Changes in network activity with the progression of Parkinson's disease. Brain 2007;130:1834-1846.
52. Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 2008;70:1470-1477.
53. Ballard C, Ziabreva I, Perry R, et al. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 2006;67:1931-1934.